NVO
Novo Nordisk
$44.01
−$0.55 (−1.23%)Sep 10, 2026
Key metrics
The numbers that frame NVO today
- Market cap
- $195.22B
- P/E (TTM)
- 10.9
- EV / FCF
- 17.7
- Gross margin
- 80.6%
- EV / Sales
- 4.1
- ROIC
- 49.5%
- Div yield
- 4.22%
- Debt / equity
- 0.6
- 52wk Low
- $34.16
- 52wk High
- $61.13
Growth
Revenue and earnings trend for NVO
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about NVO
Is Novo Nordisk a good buy?
Yes. Novo Nordisk has excellent quality and mixed momentum. Taken together, the setup leans positive. Growth looks strong, which supports the long-term business case. We think Novo Nordisk is selling at a low price.
What is the market capitalization of NVO?
Novo Nordisk's market capitalization is $195.22B.
What is the P/E ratio for NVO stock?
Novo Nordisk's current P/E ratio is 10.9.
What is the 52-week high for NVO stock?
The 52-week high for Novo Nordisk is $61.13. The current close of $44.01 is 28% below that high.
What is the 52-week low for NVO stock?
The 52-week low for Novo Nordisk is $34.16. The current close of $44.01 is 28.8% above that low.
Does NVO stock pay dividends?
Novo Nordisk pays a dividend. The latest dividend per share in the company data is $1.86, which implies a yield of 4.22% based on the current close.
What is the Debt / Equity ratio for NVO?
Novo Nordisk's Debt / Equity ratio is 0.63.